$BIO
AI AnalysisGenerated on May 11, 2026
AI Score
Hold$BIO
Bio-Rad Laboratories
$BIONYSEHealthcareLarge-Cap
Bio-Rad manufactures and sells clinical diagnostics products and life science research instruments globally.
Market Cap
$8.0B
Revenue (TTM)
$2.5B
-5.0%
Net Income (TTM)
$0.15B
-20.0%
EPS (TTM)
$5.00
P/E Ratio
62.0
Dividend Yield
0.0%
52-Week Range
$260-$420
Beta
0.62
Dimension Scores
Fundamental
54Technical
52Sentiment
58Risk / Reward
60Momentum
48Financial Health
Profitability
59moderate
Growth
51weak
Liquidity
68strong
Solvency
56moderate
Efficiency
52moderate
Valuation, technical analysis, investment thesis, risk assessment and more for $BIO
Free · No credit card required
Disclaimer: AI-generated analysis for educational purposes only. Not financial advice. Always consult a qualified financial advisor.